Clinical Trial Underway for Potential Long Covid Treatment
FORT LAUDERDALE, Fla. — A clinical trial is underway to assess the effectiveness and safety of sipavibart, AstraZeneca’s long-acting monoclonal antibody designed to provide protection against Covid-19, as a potential treatment for Long Covid, Nova Southeastern University (NSU) and the…… Continue Reading